Close

Sanofi Genzyme (SNY) Receives $37.6M BARDA Contract

October 6, 2016 4:01 PM EDT Send to a Friend
Sanofi Genzyme, the specialty care global business unit of Sanofi (NYSE: SNY), announced today that the Biomedical Advanced Research and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login